BlackRock’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120M | Sell |
8,532,761
-359,576
| -4% | -$5.04M | ﹤0.01% | 1913 |
|
|
2025
Q1 | $139M | Sell |
8,892,337
-256,221
| -3% | -$4.01M | ﹤0.01% | 1788 |
|
|
2024
Q4 | $127M | Buy |
9,148,558
+119,002
| +1% | +$1.66M | ﹤0.01% | 1923 |
|
|
2024
Q3 | $84M | Buy |
9,029,556
+406,938
| +5% | +$3.78M | ﹤0.01% | 2158 |
|
|
2024
Q2 | $80.2M | Buy |
8,622,618
+1,963,877
| +29% | +$18.3M | ﹤0.01% | 2136 |
|
|
2024
Q1 | $66M | Buy |
6,658,741
+742,195
| +13% | +$7.36M | ﹤0.01% | 2260 |
|
|
2023
Q4 | $19.1M | Buy |
5,916,546
+1,896,145
| +47% | +$6.12M | ﹤0.01% | 2979 |
|
|
2023
Q3 | $21.3M | Sell |
4,020,401
-210,973
| -5% | -$1.12M | ﹤0.01% | 2861 |
|
|
2023
Q2 | $40.3M | Sell |
4,231,374
-366,898
| -8% | -$3.5M | ﹤0.01% | 2574 |
|
|
2023
Q1 | $50.6M | Sell |
4,598,272
-615,986
| -12% | -$6.78M | ﹤0.01% | 2401 |
|
|
2022
Q4 | $77.2M | Buy |
5,214,258
+132,514
| +3% | +$1.96M | ﹤0.01% | 2168 |
|
|
2022
Q3 | $97.1M | Buy |
5,081,744
+503,591
| +11% | +$9.62M | ﹤0.01% | 1968 |
|
|
2022
Q2 | $97.6M | Buy |
4,578,153
+262,351
| +6% | +$5.59M | ﹤0.01% | 2000 |
|
|
2022
Q1 | $83.1M | Buy |
4,315,802
+1,938
| +0% | +$37.3K | ﹤0.01% | 2226 |
|
|
2021
Q4 | $89.5M | Buy |
4,313,864
+117,938
| +3% | +$2.45M | ﹤0.01% | 2263 |
|
|
2021
Q3 | $100M | Sell |
4,195,926
-52,694
| -1% | -$1.26M | ﹤0.01% | 2186 |
|
|
2021
Q2 | $116M | Buy |
4,248,620
+46,661
| +1% | +$1.27M | ﹤0.01% | 2147 |
|
|
2021
Q1 | $122M | Buy |
4,201,959
+1,306,905
| +45% | +$37.8M | ﹤0.01% | 2060 |
|
|
2020
Q4 | $81.4M | Buy |
2,895,054
+838,668
| +41% | +$23.6M | ﹤0.01% | 2169 |
|
|
2020
Q3 | $60.3M | Buy |
2,056,386
+489,812
| +31% | +$14.4M | ﹤0.01% | 2138 |
|
|
2020
Q2 | $47.4M | Buy |
1,566,574
+701,265
| +81% | +$21.2M | ﹤0.01% | 2253 |
|
|
2020
Q1 | $25.8M | Buy |
+865,309
| New | +$25.8M | ﹤0.01% | 2444 |
|